Systems, devices and methods are disclosed for a prescription-regulated software application and an associated medical device. In some aspects, a smart medicine-injection device (e.g., smart insulin pen) is configured to be in communication with a patient's companion device (e.g., smartphone) having a software application (prescription app) that serves the patient as a complimentary medical device to the smart medicine-injection device, in which only certain features and functionalities of the prescription app are fully operable based on device pairing with the smart medicine-injection device to unlock medical device capabilities only available to the patient through prescription.
Legal claims defining the scope of protection, as filed with the USPTO.
2. The method of claim 1, wherein the received wireless signal includes a security code, and wherein the method comprises storing the security code in a memory of mobile device.
3. The method of claim 2, wherein the security code is a unique security code that only corresponds to a patient user who has been prescribed the medical device.
5. The method of claim 1, wherein the received wireless signal includes a validation code included in a pairing protocol, and wherein the enabling includes processing the validation code to compare to a predetermined authorization code contained within the obtained software application.
6. The method of claim 1, wherein the medical device includes a medicine injection pen and/or medicine injection pump.
7. The method of claim 1, wherein the mobile device is implemented on a smartphone, a tablet, and/or a wearable device.
8. The method of claim 1, wherein the software application is operable on the mobile device to cause the mobile device to display a default screen prior to enabling as operable the one or more prescription-regulated operational features.
9. The method of claim 8, wherein the default screen includes one or more of an indicator that the pairing is undergoing, a list of trouble-shooting steps should the pairing be impaired or unsuccessful, or a contact information for a user to seek assistance with the pairing process.
10. The method of claim 1, wherein the wireless signal is received using a Bluetooth, Bluetooth Low Energy (BLE), and/or Near Field Communication (NFC) protocol.
12. The method of claim 11, wherein the medically-prescribed injection device includes a medicine injection pen and/or medicine injection pump.
13. The method of claim 11, wherein the mobile device is implemented on a smartphone, a tablet, and/or a wearable device.
14. The method of claim 11, wherein the medically-regulated software application is operable on the mobile device to cause the mobile device to display a default screen prior to enabling as operable the one or more prescription-regulated operational features.
15. The method of claim 14, wherein the default screen includes one or more of an indicator that the pairing is undergoing, a list of trouble-shooting steps should the pairing be impaired or unsuccessful, or a contact information for a user to seek assistance with the pairing process.
16. The method of claim 11, wherein the wireless transmission includes a signal in accordance with a Bluetooth, Bluetooth Low Energy (BLE), and/or Near Field Communication (NFC) protocol.
18. The method of claim 17, wherein the medically-prescribed injection device includes a medicine injection pen and/or medicine injection pump.
19. The method of claim 17, wherein the mobile device is implemented on a smartphone, a tablet, and/or a wearable device.
20. The method of claim 17, wherein the wireless transmission includes a signal in accordance with a Bluetooth, Bluetooth Low Energy (BLE), and/or Near Field Communication (NFC) protocol.
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
May 7, 2019
May 30, 2023
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.